SelvitaWAR:SLV +0.48%80 PEG Ratio is 0.00 as of Jul. 04, 2026. GuruFocus rates WAR:SLV with a GF Score™ of 80/100 and a GF Value™ of zł58.63 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 36 Medical Diagnostics & Research companies, Selvita ranks worse than 2777775% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Selvita's PE Ratio without NRI is 0.00. Selvita's 5-Year EBITDA growth rate is 10.60%. Therefore, Selvita's PEG Ratio for today is 0.00.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Selvita's PEG Ratio or its related term are showing as below:
During the past 11 years, Selvita's highest PEG Ratio was 74.20. The lowest was 21.07. And the median was 41.82.
WAR:SLV's PEG Ratio is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 2.385 * Ranked among companies with meaningful PEG Ratio only.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Selvita (WAR:SLV) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Selvita PEG Ratio Related Terms
Selvita PEG Ratio Historical Data
* Premium members only.
The historical data trend for Selvita's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Selvita's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selvita PEG Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Selvita's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Selvita's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Selvita (WAR:SLV) has a PEG Ratio of 0.00 as of Jul. 04, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Selvita and its competitors. Over the past decade, Selvita's PEG Ratio has ranged from 21.07 to 74.20. According to the industry distribution chart, Selvita ranks #999999 out of 36 companies in the Medical Diagnostics & Research industry.
Is Selvita's PEG Ratio too high?
Selvita's current PEG Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 21.07 to a high of 74.20. Based on the distribution chart, Selvita ranks #999999 out of 36 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Selvita has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Selvita's PEG Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Selvita ranks #999999 out of 36 companies for PEG Ratio. This places Selvita in the lower half of its industry. The industry median PEG Ratio is 2.39. Historically, Selvita's own PEG Ratio has ranged from 21.07 to 74.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Diagnostics & Research company?
The median PEG Ratio among Medical Diagnostics & Research companies is 2.39, based on 36 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Selvita and its competitors. For the Medical Diagnostics & Research industry, the median PEG Ratio is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selvita's current PEG Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selvita stock overvalued right now?
Based on GuruFocus' analysis, Selvita (WAR:SLV) is currently considered Significantly Undervalued. The stock's GF Value™ is zł58.63, compared to a current price of zł31.40 — trading 46.4% below its estimated fair value. The current PEG Ratio is 0.00. Selvita's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Selvita (WAR:SLV), the current PEG Ratio is 0.00 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selvita (WAR:SLV) Overvalued in 2026?
Based on GuruFocus' analysis, Selvita stock appears to be undervalued.
The current stock price of zł31.40 is trading 46.4% below its estimated GF Value™ of zł58.63.
GuruFocus considers Selvita to be Significantly Undervalued.
Key valuation signals for WAR:SLV:
PEG Ratio: 0.00
GF Value™: zł58.63 vs. price of zł31.40 (46.4% below fair value)
No single metric tells the full story. See the WAR:SLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.
80GF Score
Get the complete analysis for WAR:SLV
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SLV has been successfully added to your 
